OIIM [O2MICRO INTERNATIONAL] 6-K: (Original Filing)

[O2Micro Reports Third Quarter Financial Results GEORGE TOWN, Grand Cayman, Nov. 4, 2009 (GLOBE NEWSWIRE) -- O2Micro(R) International Limited (Nasdaq:OIIM) reported its financial results today for the third quarter ended September 30, 2009. Financial Results for the Third Quarter ending 9/30/2009: O2Micro(R) International reported Q3 2009 GAAP revenue of $36.7 million. Q3 revenue increased by 6.0% from Q2 2009 and]

By | 2016-03-02T00:13:22+00:00 November 9th, 2009|Categories: Chinese Stocks, OIIM, SEC Original|Tags: , , , , , |0 Comments

OIIM [O2MICRO INTERNATIONAL] 6-K: O2Micro Reports Third Quarter Financial Results GEORGE TOWN,

[O2Micro Reports Third Quarter Financial Results GEORGE TOWN, Grand Cayman, Nov. 4, 2009 (GLOBE NEWSWIRE) -- O2Micro(R) International Limited (Nasdaq:OIIM) reported its financial results today for the third quarter ended September 30, 2009. Financial Results for the Third Quarter ending 9/30/2009: O2Micro(R) International reported Q3 2009 GAAP revenue of $36.7 million. Q3 revenue increased by 6.0% from Q2 2009 and]

By | 2016-03-02T00:15:51+00:00 November 9th, 2009|Categories: Chinese Stocks, OIIM, Webplus ver|Tags: , , , , , |0 Comments

EVK [Ever-Glory International,] 10-Q: (Original Filing)

[EVER-GLORY INTERNATIONAL GROUP, INC. FORM 10-Q INDEX Page Number 3 PART I. FINANCIAL INFORMATION 4 Item 1. Financial Statements 4 Condensed Consolidated Balance Sheets as of September 30, 2009 (unaudited) and December 31, 2008 4] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Edward Yihua Kang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Yan Guo, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Edward Yihua Kang Chief Executive Officer EX-32.1 4 v165241_ex32-1.htm] [OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Yan Guo Chief Finance Officer (Principal Finance Officer) EX-32.2 5 v165241_ex32-2.htm]

EVK [Ever-Glory International,] 10-Q: EVER-GLORY INTERNATIONAL GROUP, INC. FORM 10-Q INDEX Page

[EVER-GLORY INTERNATIONAL GROUP, INC. FORM 10-Q INDEX Page Number 3 PART I. FINANCIAL INFORMATION 4 Item 1. Financial Statements 4 Condensed Consolidated Balance Sheets as of September 30, 2009 (unaudited) and December 31, 2008 4] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Edward Yihua Kang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Yan Guo, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Edward Yihua Kang Chief Executive Officer EX-32.1 4 v165241_ex32-1.htm] [OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Yan Guo Chief Finance Officer (Principal Finance Officer) EX-32.2 5 v165241_ex32-2.htm]

ACTS [Actions Semiconductor] 6-K: Actions Semiconductor Reports Third Quarter 2009 Results ZHUHAI,

[Actions Semiconductor Reports Third Quarter 2009 Results ZHUHAI, China, November 5, 2009 – Actions Semiconductor Co., Ltd. (Nasdaq: ACTS), one of China’s leading fabless semiconductor companies that provides comprehensive mixed-signal system-on-a-chip (SoC) and multimedia digital signal processing (DSP) solutions for portable consumer electronics, today reported its financial results for the third quarter ended September 30, 2009. All financial results are] [Actions Semiconductor Promotes Niccolo Chen to Chief Executive Officer Robin Pan, Industry Veteran, Added to the Board Nan-Horng Yeh, Former CEO, Remains on Board ZHUHAI, China, November 5, 2009 – Actions Semiconductor Co., Ltd. (Nasdaq: ACTS), one of China’s leading fabless semiconductor companies that provides comprehensive mixed-signal system-on-a-chip (SoC) and multimedia digital signal processing (DSP) solutions for portable consumer electronics,] [Commission File No. 000-51604 ACTIONS SEMICONDUCTOR CO., LTD. 15-1, No. 1 HIT Road Tangjia, Zhuhai Guangdong, 519085 The People’s Republic of China (86-756) 339-2353 x ¨ Form 20-F ¨ ¨ Yes ¨ No x (2) Press announcement dated November 5, 2009, entitled “Actions Semiconductor Promotes Niccolo Chen to Chief Executive Officer.” ACTIONS SEMICONDUCTOR CO., LTD.]

By | 2016-03-27T23:56:16+00:00 November 9th, 2009|Categories: ACTS, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[BIOSTAR PHARMACEUTICALS, INC. TO PRESENT AT THE BREAN MURRAY, CARRET & CO. CHINA GROWTH CONFERENCE Press Release Source: Biostar Pharmaceuticals, Inc. On 8:00 am EST, Wednesday November 4, 2009 BSPM News ; XIANYANG, China, Nov. 4 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: Mr. Ronghua Wang, Chief Executive Officer and Ms. Elaine Zhao, Chief Financial Officer, are scheduled to] [BIOSTAR PHARMACEUTICALS ANNOUNCES CLOSING OF A $3.6 MILLION EQUITY FINANCING Press Release Source: Biostar Pharmaceuticals, Inc. On 8:00 am EST, Friday November 6, 2009 BSPM News ; XIANYANG, China, Nov. 6 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: After completing this transaction, Biostar has approximately 26.1 million shares outstanding on a diluted basis. "After evaluating several financing options to] [BIOSTAR PHARMACEUTICALS, INC. TO HOST FISCAL YEAR 2009 THIRD QUARTER EARNINGS CONFERENCE CALL ON THURSDAY, NOVEMBER 12, 2009 AT 9:30 A.M. ET Press Release Source: Biostar Pharmaceuticals, Inc. On 8:00 am EST, Monday November 9, 2009 BSPM News ; XIANYANG, China, Nov. 9 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: http://www.viavid.net http://viavid.net/dce.aspx?sid=00006CE5 http://www.microsoft.com/windows/windowsmedia/en/download/default.asp This call is being web cast]

By | 2016-03-03T15:37:25+00:00 November 9th, 2009|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, INC. TO PRESENT AT THE BREAN

[BIOSTAR PHARMACEUTICALS, INC. TO PRESENT AT THE BREAN MURRAY, CARRET & CO. CHINA GROWTH CONFERENCE Press Release Source: Biostar Pharmaceuticals, Inc. On 8:00 am EST, Wednesday November 4, 2009 BSPM News ; XIANYANG, China, Nov. 4 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: Mr. Ronghua Wang, Chief Executive Officer and Ms. Elaine Zhao, Chief Financial Officer, are scheduled to] [BIOSTAR PHARMACEUTICALS ANNOUNCES CLOSING OF A $3.6 MILLION EQUITY FINANCING Press Release Source: Biostar Pharmaceuticals, Inc. On 8:00 am EST, Friday November 6, 2009 BSPM News ; XIANYANG, China, Nov. 6 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: After completing this transaction, Biostar has approximately 26.1 million shares outstanding on a diluted basis. "After evaluating several financing options to] [BIOSTAR PHARMACEUTICALS, INC. TO HOST FISCAL YEAR 2009 THIRD QUARTER EARNINGS CONFERENCE CALL ON THURSDAY, NOVEMBER 12, 2009 AT 9:30 A.M. ET Press Release Source: Biostar Pharmaceuticals, Inc. On 8:00 am EST, Monday November 9, 2009 BSPM News ; XIANYANG, China, Nov. 9 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: http://www.viavid.net http://viavid.net/dce.aspx?sid=00006CE5 http://www.microsoft.com/windows/windowsmedia/en/download/default.asp This call is being web cast]

By | 2016-03-03T15:39:44+00:00 November 9th, 2009|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

CHOP [China Gerui Advanced Materials] EFFECT: (Original Filing)

[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .FormText {font-size: x-small; font-family: arial, helvetica, sans-serif} .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif} .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold} .FormName {font-size: large; font-family: arial, helvetica, sans-serif;]

Skip to toolbar